D. Deck

Does doxycycline protect against development of Clostridium difficile infection?

L. Winston, H. Chambers, S. Doernberg, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review.

K. Steingart, P. Hopewell, P. Nahid, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Pharmacological advances in the treatment of invasive candidiasis

B. Guglielmo, J. Guglielmo, D. Deck, 2006, Expert review of anti-infective therapy.

Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study

J. Ramirez, P. Eckburg, Anita F. Das, 2021, Open forum infectious diseases.

Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting

T. Holland, M. Wikler, K. Sulham, 2016, Infectious Diseases and Therapy.

Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease

G. Lamichhane, Binayak Rimal, A. Serio, 2023, mSphere.

Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia

E. Vittinghoff, H. Chambers, Sanjiv M. Baxi, 2016, Antimicrobial Agents and Chemotherapy.

Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting

T. Holland, M. Wikler, K. Sulham, 2016, Infectious diseases and therapy.

Advances in Infectious Diseases: New Directions for Primary Care

D. Deck, 2014 .